CITI TRENDS INC (CTRN) Stock Fundamental Analysis

NASDAQ:CTRN • US17306X1028

45.41 USD
-0.42 (-0.92%)
At close: Feb 20, 2026
45.41 USD
0 (0%)
After Hours: 2/20/2026, 8:26:06 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CTRN. CTRN was compared to 121 industry peers in the Specialty Retail industry. CTRN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CTRN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • CTRN had negative earnings in the past year.
  • CTRN had a positive operating cash flow in the past year.
  • In multiple years CTRN reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CTRN reported negative operating cash flow in multiple years.
CTRN Yearly Net Income VS EBIT VS OCF VS FCFCTRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.53%, CTRN is doing worse than 64.46% of the companies in the same industry.
  • CTRN has a Return On Equity of -15.19%. This is comparable to the rest of the industry: CTRN outperforms 42.15% of its industry peers.
Industry RankSector Rank
ROA -3.53%
ROE -15.19%
ROIC N/A
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
CTRN Yearly ROA, ROE, ROICCTRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • Looking at the Gross Margin, with a value of 39.53%, CTRN is in line with its industry, outperforming 59.50% of the companies in the same industry.
  • CTRN's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CTRN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
CTRN Yearly Profit, Operating, Gross MarginsCTRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

6

2. Health

2.1 Basic Checks

  • CTRN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CTRN has about the same amout of shares outstanding than it did 1 year ago.
  • CTRN has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for CTRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CTRN Yearly Shares OutstandingCTRN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M
CTRN Yearly Total Debt VS Total AssetsCTRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • CTRN has an Altman-Z score of 3.14. This indicates that CTRN is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.14, CTRN is doing good in the industry, outperforming 73.55% of the companies in the same industry.
  • CTRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.14
ROIC/WACCN/A
WACC9.71%
CTRN Yearly LT Debt VS Equity VS FCFCTRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.07 indicates that CTRN should not have too much problems paying its short term obligations.
  • The Current ratio of CTRN (1.07) is worse than 67.77% of its industry peers.
  • CTRN has a Quick Ratio of 1.07. This is a bad value and indicates that CTRN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CTRN has a Quick ratio of 0.38. This is in the lower half of the industry: CTRN underperforms 61.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.38
CTRN Yearly Current Assets VS Current LiabilitesCTRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

3

3. Growth

3.1 Past

  • CTRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.31%.
  • Looking at the last year, CTRN shows a small growth in Revenue. The Revenue has grown by 5.77% in the last year.
  • Measured over the past years, CTRN shows a decrease in Revenue. The Revenue has been decreasing by -0.75% on average per year.
EPS 1Y (TTM)-22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.82%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%10.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 24.44% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 6.30% on average over the next years.
EPS Next Y82.85%
EPS Next 2Y48.15%
EPS Next 3Y34.3%
EPS Next 5Y24.44%
Revenue Next Year8.46%
Revenue Next 2Y6.79%
Revenue Next 3Y6.69%
Revenue Next 5Y6.3%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CTRN Yearly Revenue VS EstimatesCTRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
CTRN Yearly EPS VS EstimatesCTRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 -2 4 -4 6

3

4. Valuation

4.1 Price/Earnings Ratio

  • CTRN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 50.88, CTRN can be considered very expensive at the moment.
  • CTRN's Price/Forward Earnings is on the same level as the industry average.
  • CTRN is valuated expensively when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 50.88
CTRN Price Earnings VS Forward Price EarningsCTRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • CTRN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CTRN is more expensive than 69.42% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTRN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 31.74
EV/EBITDA 55.56
CTRN Per share dataCTRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CTRN's earnings are expected to grow with 34.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.15%
EPS Next 3Y34.3%

0

5. Dividend

5.1 Amount

  • CTRN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CITI TRENDS INC

NASDAQ:CTRN (2/20/2026, 8:26:06 PM)

After market: 45.41 0 (0%)

45.41

-0.42 (-0.92%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-02
Earnings (Next)06-01
Inst Owners91.73%
Inst Owner Change2.81%
Ins Owners10.77%
Ins Owner Change-0.02%
Market Cap379.17M
Revenue(TTM)800.74M
Net Income(TTM)-16.38M
Analysts82.5
Price Target58.14 (28.03%)
Short Float %6.52%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.79%
Min EPS beat(2)-9.21%
Max EPS beat(2)20.8%
EPS beat(4)2
Avg EPS beat(4)-185.43%
Min EPS beat(4)-938.78%
Max EPS beat(4)185.47%
EPS beat(8)2
Avg EPS beat(8)-131.97%
EPS beat(12)4
Avg EPS beat(12)-112.68%
EPS beat(16)7
Avg EPS beat(16)-76.95%
Revenue beat(2)1
Avg Revenue beat(2)1.21%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)3.15%
Revenue beat(4)2
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-2.13%
Max Revenue beat(4)3.15%
Revenue beat(8)2
Avg Revenue beat(8)-1.2%
Revenue beat(12)3
Avg Revenue beat(12)-1.37%
Revenue beat(16)5
Avg Revenue beat(16)-1.74%
PT rev (1m)2.7%
PT rev (3m)18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)64.89%
EPS NY rev (1m)0%
EPS NY rev (3m)21.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.84%
Revenue NY rev (1m)-2.77%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50.88
P/S 0.47
P/FCF 31.74
P/OCF 12.65
P/B 3.52
P/tB 3.52
EV/EBITDA 55.56
EPS(TTM)-3.07
EYN/A
EPS(NY)0.89
Fwd EY1.97%
FCF(TTM)1.43
FCFY3.15%
OCF(TTM)3.59
OCFY7.9%
SpS95.9
BVpS12.91
TBVpS12.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.53%
ROE -15.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.53%
FCFM 1.49%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-3.45%
ROE(5y)11.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.05%
GM growth 5Y-0.3%
F-Score6
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 99.92%
Cap/Sales 2.25%
Interest Coverage N/A
Cash Conversion 502.11%
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.38
Altman-Z 3.14
F-Score6
WACC9.71%
ROIC/WACCN/A
Cap/Depr(3y)80.1%
Cap/Depr(5y)94.79%
Cap/Sales(3y)2.05%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-12.82%
EPS Next Y82.85%
EPS Next 2Y48.15%
EPS Next 3Y34.3%
EPS Next 5Y24.44%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y-8.76%
Revenue growth 5Y-0.75%
Sales Q2Q%10.07%
Revenue Next Year8.46%
Revenue Next 2Y6.79%
Revenue Next 3Y6.69%
Revenue Next 5Y6.3%
EBIT growth 1Y64.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year130.01%
EBIT Next 3Y47.07%
EBIT Next 5Y31.46%
FCF growth 1Y164.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y855.19%
OCF growth 3YN/A
OCF growth 5YN/A

CITI TRENDS INC / CTRN FAQ

What is the fundamental rating for CTRN stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTRN.


What is the valuation status for CTRN stock?

ChartMill assigns a valuation rating of 3 / 10 to CITI TRENDS INC (CTRN). This can be considered as Overvalued.


How profitable is CITI TRENDS INC (CTRN) stock?

CITI TRENDS INC (CTRN) has a profitability rating of 2 / 10.


What is the financial health of CITI TRENDS INC (CTRN) stock?

The financial health rating of CITI TRENDS INC (CTRN) is 6 / 10.


Can you provide the dividend sustainability for CTRN stock?

The dividend rating of CITI TRENDS INC (CTRN) is 0 / 10 and the dividend payout ratio is 0%.